China Pharma Holdings (CPHI) Common Equity (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Common Equity came in at $37.0 million in Q1 2026, up 431.21% YoY from $7.0 million in Q1 2025, and up 20468.99% on a QoQ basis from $180000.0 in Q4 2025.
China Pharma Holdings (CPHI) Common Equity (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Common Equity data on file, last reported at $37.0 million in Q1 2026.
- Quarterly Common Equity rose 431.21% year-over-year to $37.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.0 million (up 431.21% YoY) and the FY2025 annual result came in at $180000.0, down 97.68% from the prior year.
- Common Equity grew to $37.0 million in Q1 2026, from $180000.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of $37.0 million in Q1 2026 to a low of $180000.0 in Q3 2025.
- A 5-year average of $7.1 million and a median of $6.1 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2025 — Common Equity slumped 97.68% — and 2026, when it soared 431.21%.
- Tracing CPHI's Common Equity over 5 years: stood at $4.3 million in 2022, then soared by 73.77% to $7.5 million in 2023, then increased by 3.93% to $7.7 million in 2024, then tumbled by 97.68% to $180000.0 in 2025, then jumped by 20468.99% to $37.0 million in 2026.
- The last three Common Equity figures came in at $37.0 million (Q1 2026), $180000.0 (Q4 2025), and $180000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 36.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.02 Mn |
| Dec 31, 2025 | 180,000.00 |
| Sep 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 6.46 Mn |
| Mar 31, 2025 | 6.97 Mn |
| Dec 31, 2024 | 7.75 Mn |
| Sep 30, 2024 | 6.53 Mn |
| Jun 30, 2024 | 7.41 Mn |
| Mar 31, 2024 | 8.29 Mn |
| Dec 31, 2023 | 7.45 Mn |
| Sep 30, 2023 | 6.11 Mn |
| Jun 30, 2023 | 4.35 Mn |
| Mar 31, 2023 | 4.67 Mn |
| Dec 31, 2022 | 4.29 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 5.34 Mn |
| Dec 31, 2021 | 6.02 Mn |
| Sep 30, 2021 | 6.85 Mn |
| Jun 30, 2021 | 6.52 Mn |